GGrantIndex
← Leaderboards

Tomas Vaisar

University Of Washington

$10,474,916
Attributed
$12,263,679
Total exposure
10
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200825
$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,263,679 · 10

By mechanism

P01$6,405,430 · 6
R01$2,793,099 · 1
U01$2,123,110 · 1
P30$942,040 · 2

Top collaborators

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Proteins

Research focus

ProteinsMolecularProteomicsAnalytical ToolHuman ResourcesLaboratoriesResearch PersonnelLiquid ChromatographyShotgunsInstrumentationServicesCost EffectivenessMass Spectrum AnalysisHigh Density LipoproteinsBiologicalDiabetes MellitusAnalytical MethodComplexElectrospray IonizationProteomeData SetLipoproteinsIsotopesBioinformatics

Grant awards (36)

Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank$1,042,430
U01 · FY2025 · DK
Lipoprotein Quantitation and Function Core$323,638
P01 · FY2025 · HL · contact PI
Core B: Proteomics and lipoprotein characterization core$236,360
P01 · FY2025 · HL · contact PI
PROTEOMICS AND BIOINFORMATICS CORE$179,312
P30 · FY2025 · DK · contact PI
Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank$1,080,680
U01 · FY2024 · DK
Lipoprotein Quantitation and Function Core$313,438
P01 · FY2024 · HL · contact PI
PROTEOMICS AND BIOINFORMATICS CORE$179,310
P30 · FY2024 · DK · contact PI
Core B: Proteomics and lipoprotein characterization core$171,322
P01 · FY2024 · HL · contact PI
Lipoprotein Quantitation and Function Core$330,327
P01 · FY2023 · HL · contact PI
PROTEOMICS AND BIOINFORMATICS CORE$179,312
P30 · FY2023 · DK · contact PI
Core B: Proteomics and lipoprotein characterization core$174,483
P01 · FY2023 · HL · contact PI
HDL composition/function and cardiovascular risk in youths with diabetes$631,046
R01 · FY2022 · HL · contact PI
Core B: Proteomics and lipoprotein characterization core$173,539
P01 · FY2022 · HL · contact PI
Quantitative and Functional Proteomics Core$139,274
P30 · FY2022 · DK · contact PI
HDL composition/function and cardiovascular risk in youths with diabetes$650,228
R01 · FY2021 · HL · contact PI
Core B: Proteomics and lipoprotein characterization core$173,476
P01 · FY2021 · HL · contact PI
Quantitative and Functional Proteomics Core$132,526
P30 · FY2021 · DK · contact PI
HDL composition/function and cardiovascular risk in youths with diabetes$684,499
R01 · FY2020 · HL · contact PI
Core C - HDL Quantitation$542,506
P01 · FY2020 · HL · contact PI
Core B: Proteomics and lipoprotein characterization core$177,776
P01 · FY2020 · HL · contact PI
HDL composition/function and cardiovascular risk in youths with diabetes$827,326
R01 · FY2019 · HL · contact PI
Core C - HDL Quantitation$542,506
P01 · FY2019 · HL · contact PI
Core B: Quantitative and Functional HDL Core$170,814
P01 · FY2019 · HL · contact PI
Quantitative and Functional Proteomics Core$132,306
P30 · FY2019 · DK · contact PI
Core C - HDL Quantitation$542,506
P01 · FY2018 · HL · contact PI
Core B: Quantitative and Functional HDL Core$175,236
P01 · FY2018 · HL · contact PI
Core C - HDL Quantitation$542,506
P01 · FY2017 · HL · contact PI
Core B: Quantitative and Functional HDL Core$175,228
P01 · FY2017 · HL · contact PI
Core C - HDL Quantitation$557,006
P01 · FY2016 · HL · contact PI
Core B: Quantitative and Functional HDL Core$168,025
P01 · FY2016 · HL · contact PI
Core B: Quantitative and Functional HDL Core$168,025
P01 · FY2015 · HL · contact PI
Core C Mass Spectrometry Core$149,342
P01 · FY2012 · HL
Core C Mass Spectrometry Core$149,344
P01 · FY2011 · HL
Core C Mass Spectrometry Core$149,344
P01 · FY2010 · HL
Core C Mass Spectrometry Core$149,344
P01 · FY2009 · HL
Core C Mass Spectrometry Core$149,339
P01 · FY2008 · HL